Dennis Langer - 30 Jun 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Director
Signature: By: Natalie Munk For: Dennis H. Langer
Issuer symbol: MYGN
Transactions as of: 30 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 30 Jun 2022, 16:37:04 UTC
Previous filing: 03 Jun 2022
Next filing: 07 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYGN	Common Stock						106,802	30 Jun 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MYGN	Non-Qualified Stock Option (right to buy)						30,000	30 Jun 2022	Common Stock	30,000	$27.61	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Dennis Langer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as a Company Board of Director, effective June 30, 2022, and therefore is no longer subject to Section 16 reporting.